Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ypsomed Holding AGYPHDF 94 12-1 Month Momentum % is -9.51% as of Aug. 12, 2026. GuruFocus rates YPHDF with a GF Score™ of 94/100 and a GF Value™ of $461.36 (Fairly Valued). The stock has 5 warning signs investors should review. Among 829 Medical Devices & Instruments companies, Ypsomed Holding AG ranks better than 62% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-12), Ypsomed Holding AG's 12-1 Month Momentum % is -9.51%.
The industry rank for Ypsomed Holding AG's 12-1 Month Momentum % or its related term are showing as below:
YPHDF's 12-1 Month Momentum % is ranked better than 62% of 829
companies
in the Medical Devices & Instruments industry
Industry Median: -16.95
vs YPHDF: -9.51
Ypsomed Holding AG (OTCPK:YPHDF) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Ypsomed Holding AG 12-1 Month Momentum % Related Terms
YPHDF vs ISRG, BDX, MDLN: 12-1 Month Momentum % Comparison
For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ypsomed Holding AG 12-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Ypsomed Holding AG's 12-1 Month Momentum % falls into.
Ypsomed Holding AG (OTCPK:YPHDF) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ypsomed Holding AG (YPHDF) has a 12-1 Month Momentum % of -9.51% as of Aug. 12, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Ypsomed Holding AG and its competitors. According to the industry distribution chart, Ypsomed Holding AG ranks #315 out of 829 companies in the Medical Devices & Instruments industry, placing it in the top 38%.
Is Ypsomed Holding AG's 12-1 Month Momentum % too high?
Ypsomed Holding AG's current 12-1 Month Momentum % is -9.51%. Based on the distribution chart, Ypsomed Holding AG ranks #315 out of 829 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Ypsomed Holding AG has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's 12-1 Month Momentum % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ypsomed Holding AG ranks #315 out of 829 companies for 12-1 Month Momentum %. This puts Ypsomed Holding AG in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Medical Devices & Instruments company?
A good 12-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Ypsomed Holding AG and its competitors. Ypsomed Holding AG's current 12-1 Month Momentum % is -9.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (YPHDF) is currently considered Fairly Valued. The stock's GF Value™ is $461.36, compared to a current price of $476.49 — trading 3.3% above its estimated fair value. The current 12-1 Month Momentum % is -9.51%. Ypsomed Holding AG's overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Ypsomed Holding AG (YPHDF), the current 12-1 Month Momentum % is -9.51% as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ypsomed Holding AG (YPHDF) Overvalued in 2026?
Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be overvalued.
The current stock price of $476.49 is trading 3.3% above its estimated GF Value™ of $461.36.
GuruFocus considers Ypsomed Holding AG to be Fairly Valued.
Key valuation signals for YPHDF:
12-1 Month Momentum %: -9.51%
GF Value™: $461.36 vs. price of $476.49 (3.3% above fair value)
No single metric tells the full story. See the YPHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
94GF Score
Get the complete analysis for YPHDF
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
YPHDF has been successfully added to your 
